Literature DB >> 33911554

Benign Atypical Intralymphatic CD30+ T-Cell Proliferation: A Case Report and Literature Review.

Nu Ri Jang1, Min Kyoung Kim2, Dong Hoon Shin3, Mi Jin Gu1.   

Abstract

Entities:  

Year:  2019        PMID： 33911554      PMCID： PMC7992704          DOI： 10.5021/ad.2019.31.1.108

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  5 in total

Review 1.  Benign atypical intravascular CD30+ T-cell proliferation: a recently described reactive lymphoproliferative process and simulator of intravascular lymphoma: report of a case associated with lichen sclerosus and review of the literature.

Authors:  Werner Kempf; Katarzyna Keller; Hubert John; Corina Dommann-Scherrer
Journal:  Am J Clin Pathol       Date:  2014-11       Impact factor: 2.493

2.  Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.

Authors:  Erica Riveiro-Falkenbach; María Teresa Fernández-Figueras; José Luis Rodríguez-Peralto
Journal:  Am J Dermatopathol       Date:  2013-04       Impact factor: 1.533

Review 3.  Unusual variants of intravascular malignant hematopoietic neoplasms: a report of 4 cases and review of the literature.

Authors:  Giang Huong Nguyen; Aminah H Yassin; Cynthia M Magro
Journal:  Am J Dermatopathol       Date:  2015-05       Impact factor: 1.533

4.  Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.

Authors:  Mark A Samols; Albert Su; Seong Ra; Mark A Cappel; Abner Louissant; Ryan A Knudson; Rhett P Ketterling; Jonathan Said; Scott Binder; Nancy Lee Harris; Andrew L Feldman; Jinah Kim; Youn H Kim; Dita Gratzinger
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

5.  Intralymphatic Proliferation of T-cell Lymphoid Blasts in the Setting of Hidradenitis Suppurativa.

Authors:  Paola Calamaro; Lorenzo Cerroni
Journal:  Am J Dermatopathol       Date:  2016-07       Impact factor: 1.533
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.